首页 | 本学科首页   官方微博 | 高级检索  
     

利喜定和优匹敌治疗重症高血压的费用-效果分析
引用本文:冯新生,唐萍,董福祥. 利喜定和优匹敌治疗重症高血压的费用-效果分析[J]. 中国药房, 2002, 13(9): 536-537
作者姓名:冯新生  唐萍  董福祥
作者单位:1. 河南省直机关第二医院,郑州市450003
2. 河南省人民医院,郑州市450003
摘    要:目的 :探讨国产和进口乌拉地尔注射液对重症高血压的治疗效果和经济效果。方法 :重症高血压患者80例 ,随机分为Ⅰ组和Ⅱ组 ,Ⅰ组给予国产乌拉地尔 (利喜定 )注射液 ,Ⅱ组给予进口乌拉地尔 (优匹敌 )注射液 ,运用药物经济学中的费用 -效果分析方法进行比较。结果 :Ⅰ组治疗有效率为90 0 % ,Ⅱ组治疗有效率为92 5 % ,两组间无显著性差异 (P>0 05) ,但治疗费用上却有明显差异。结论 :药物经济学在指导临床合理用药、减轻患者经济负担方面具有重要意义。

关 键 词:费用-效果分析  重症高血压  利喜定  优匹敌  乌拉地尔
文章编号:1001-0408(2002)09-0536-02
修稿时间:2002-05-27

Cost- effectiveness Analysis of Lixiding and Ebrantil in Treatment of Severe Hypertensive
FENG Xinsheng. Cost- effectiveness Analysis of Lixiding and Ebrantil in Treatment of Severe Hypertensive[J]. China Pharmacy, 2002, 13(9): 536-537
Authors:FENG Xinsheng
Abstract:OBJECTIVE:To compare the therapeutic effect and cost of domestic Urapidil injection(Lixiding)with those of imported Urapidil injection(Ebrantil)in treatment of severe hypertensive METHODS:80 cases of severe hypertensive were randomly divided into two groups:group Ⅰ,Lixiding;group Ⅱ,Ebrantil The two groups were compared with cost-effectiveness analysis RESULTS:The effective rates of group Ⅰ and groupⅡ were 90 0% and 92 5% respectively,there was no significant difference between two groups(P>0 05) in therapeutic effect,but the costs were significantly different CONCLUSI_ON:Pharmacoeconomics plays an important role in guiding rational use of drug and in lightening the patients'expense
Keywords:cost-effectiveness analysis  severe hypertensive  Lixiding  Ebrantil  Urapidil
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号